Planned Parenthood PA Advocates Responds to Scotus Action on Medication Abortion
For Immediate Release: Dec. 13, 2023 (Updated: Dec. 13, 2023, 4:19 p.m.)
(Harrisburg, Pa.) — Planned Parenthood PA Executive Director Signe Espinoza released the following statement on the Supreme Court of the United States’ decision to take up the mifepristone case. Before its ruling, there is no change in access to medication abortion.
“We have grave concerns about pending Supreme Court action on access to mifepristone, one of the most common drugs prescribed for medication abortion. This court has shown nothing but contempt for our right to essential, private medical care and have ruled as if they know more about our health and bodies than we do, or our doctors do. While we wait on their decision, there will be no change in access to mifepristone. Pennsylvanians should continue to seek the care they need with their trusted health care provider.”
For more information on PPPA and access to abortion care in Pennsylvania, please visit our website.
MEDIA CONTACT: Brittany Crampsie, 717 712 3480
###
ABOUT PLANNED PARENTHOOD PENNSYLVANIA ADVOCATES
Planned Parenthood Pennsylvania Advocates (PPPA) exists to create a Pennsylvania where sexual and reproductive healthcare, including abortion, is accessible, affordable, and affirming for all. We achieve this, in partnership with the 3 Planned Parenthood affiliates in Pennsylvania, through electoral and advocacy campaigns, lobbying, and organizing.